horse racing medication

NHBPA: Book on world equine drug testing rules now available

The fourth edition of “World Rules for Equine Drug Testing and Therapeutic Medication Regulation: 2012 Policy of the National Horsemen’s Benevolent and Protective Association, Inc.” was released on February 14 by Wind Publications. Authors of the 286-page book are Thomas Tobin, MVB, MSc, PhD, MRCVS, DABT, professor at the University of Kentucky Gluck Equine Research […]

Continue reading
The Breeders’ Cup Forum: Dr. J. David Richardson

Dr. J. David Richardson is chairman of the Thoroughbred Owners and Breeders Association’s American Graded Stakes Committee that voted last August to require all 2-year-old graded stakes of 2012 to be run free of race-day medication, including the diuretic furosemide, or Lasix. Last week, however, TOBA announced it was delaying implementation of that requirement. The […]

Continue reading
Graded Stakes Committee: No race day medication ban for juveniles this year

The TOBA American Graded Stakes Committee has announced that it will not implement a ban of race-day medication for two-year old graded stakes races in 2012, but will continue to work with racing officials, state regulators and others within the industry to advance the goal of conducting American Graded Stakes races at the highest level […]

Continue reading
Fortus: ‘Needless bickering’ sabotages Louisiana racing

Bob Fortus writes for the Times-Picayune that the Louisiana Horse Racing Commission needs to step up and lead on the issue of drug rules.  Last fall, the commission passed an emergency rule that lowered allowable levels of Bute to comply with an American Graded Stakes Committee requirement.  Lousiana horsemen challenged the rule on the grounds […]

Continue reading
Kentucky panel recommends medication rule changes

An advisory committee recommended changes to Kentucky’s horse racing medication rules and disciplinary measures Wednesday.  Among the changes – an owner who claims a horse that tests positive after the claiming race could void the claim.  The connections of the horse testing positive would be responsible for expenses of the new owner from the time […]

Continue reading
Outgoing equine medical director urges reform in Louisiana

Dr. Tom David recently resigned as equine medical director for the Louisiana State Racing Commission – effective January 1st – but he’s not going quietly when it comes to his push for medication reform and opinions on other issues, reports the Times-Picayune: “At this point, Louisiana is not moving forward with changes on medication that […]

Continue reading
British authorities make changes to medication detection times

The British Horseracing Authority today announces four new Detection Times for commonly used veterinary medicines; the sedative acepromazine, the sedative/analgesic combination detomidine/butorphanol, the anti-inflammatory treatment prednisolone, and the airway treatment salmeterol. The work to produce these Detection Times was performed at the Authority’s Centre for Racehorse Studies and its contractor laboratory HFL Sport Science.  Click […]

Continue reading
NTRA board: all talk, no action on medication policy

Within 24 hours of a Paulick Report commentary on the need for the Thoroughbred industry to consolidate some of its numerous alphabet soup organizations, the NTRA (National Thoroughbred Racing Association) sent out the following press release: “The NTRA Board of Directors met Tuesday in Lexington, Ky., to discuss recent calls by individuals and organizations to […]

Continue reading
Twitter Twitter
Paulick Report on Instagram